
Indee Labs: Pioneering non-viral gene delivery for T cell therapy with µVS technology.
Indee Labs, founded with the mission to revolutionize T cell immunotherapy, focuses on developing non-viral intracellular delivery systems. Their core technology, microfluidic vortex shedding (µVS), enables the rapid delivery of nucleic acids, proteins, and gene-editing complexes to patient and donor T cells with minimal perturbation. The company's flagship product, Hydropore™, is designed to accelerate the discovery, development, and manufacturing of engineered cell therapies, ensuring high cell viability and function.
Notable figures associated with Indee Labs include leading scientists and industry experts in cell therapy and gene editing. The company has secured investments from prominent venture capital firms specializing in biotechnology. Key achievements include the development and patenting of their µVS technology and successful partnerships with research institutions. Indee Labs has significantly impacted the field of cell therapy by providing a scalable, efficient, and non-viral method for intracellular delivery, advancing both research and clinical applications.

CellFE
cellfebiotech.com

Kytopen
kytopen.com

CellChorus
cellchorus.com

Scaled Biolabs
scaledbiolabs.com

Interius BioTherapeutics
interiusbio.com

Sigma Genetics
sigmagenetics.com

CyteQuest
cytequest.com

CytoRecovery
cytorecovery.com

Navan Technologies
navanbio.com

Alaya.bio
alaya.bio

Altos Labs
altoslabs.com

64x Bio
64xbio.com

Nanite
nanitebio.com

Modulari-T
modularit.bio

Strm.Bio
strm.bio
Companies similar to Indee Labs include CellFE, Kytopen, CellChorus and Scaled Biolabs.
Indee Labs was founded in 2015.
Indee Labs' headquarters is located in Berkeley, CA, US.
As of Jun 6, 2023, Indee Labs has disclosed funding of $5.1M (USD). Undisclosed round amounts are excluded.
Indee Labs has 5 employees as of Aug 23, 2023.